Thermolabile variant of 5, 10-methylenetetrahydrofolate reductaseassociated with low red-cell folates: implications for folate intake recommendations

The Lancet - Tập 349 - Trang 1591-1593 - 1997
Anne M Molloy1, Sean Daly2, James L Mills3, Peadar N Kirke4, Alexander S Whitehead5, Dorothy Ramsbottom5, Mary R Conley3, Donald G Weir1, John M Scott6
1Department of Clinical Medicine, Trinity College, Dublin 2, lerland
2Coombe Women's Hospital, Dublin
3National Institute of Child Health and Human Development, Bethesda, Maryland, USA
4Health Research Board, Dublin
5Department of Genetics and Biotechnology Institute, Trinity College, Dublin 2, lerland
6Department of Biochemistry, Trinity College, Dublin 2, lerland

Tài liệu tham khảo

Kang, 1991, Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease, Am J Hum Genet, 48, 536 Frosst, 1995, A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase, Nat Genet, 10, 111, 10.1038/ng0595-111 de Franchis, 1995, Spina bifida, 677T°C mutation and role of folate, Lancet, 346, 1703, 10.1016/S0140-6736(95)92865-0 Kirke, 1996, Methylenetetrahydrofolate reductase mutation and neural tube defects, Lancet, 348, 1037, 10.1016/S0140-6736(05)64971-9 Kang, 1993, Thermolabile defect of methylenetetrahydrofolate reductase in coronary artery disease, Circulation, 88, 1463, 10.1161/01.CIR.88.4.1463 Engbersen, 1995, Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia, Am J Hum Genet, 56, 142 Kluijtmans, 1996, Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease, Am J Hum Genet, 58, 35 Whitehead, 1995, A genetic defect in 5,10 methylenetetrahydrofolate reductase in neural tube defects, Q J Med, 88, 763 van der Put, 1995, Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida, Lancet, 346, 1070, 10.1016/S0140-6736(95)91743-8 Kang, 1988, Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase, Am J Hum Genet, 43, 414 O'Broin, 1992, Microbiological assay on microtitre plates of folate in serum red cells, J Clin Pathol, 45, 344, 10.1136/jcp.45.4.344 Kirke, 1993, Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects, Q J Med, 86, 703 Smith, 1992, Dibrisoquine hydroxylase gene polymorphism and susceptibility to Parkinson's disease, Lancet, 339, 1375, 10.1016/0140-6736(92)91196-F Visy, 1991, Homocysteinuria due to 5,10 methylenetetrahydrofolate reductase deficiency revealed by stroke in adult siblings, Neurology, 41, 1313, 10.1212/WNL.41.8.1313 Rosenblatt, 1979, Folate distribution in cultured cells: studies on 5,10-CH2-H4PteGlu reductase deficiency, J Clin Invest, 63, 1019, 10.1172/JCI109370 Baumgartner, 1985, Comparison of folic acid coenzyme distribution patterns in patients with methylenetetrahydrofolate reductase and methionine synthetase deficiencies, Pediatr Res, 19, 1288, 10.1203/00006450-198512000-00017 Chanarin, 1990 Boushey, 1995, A quantitative assessment of plasma homocysteine as a risk factor for vascular disease, JAMA, 274, 1049, 10.1001/jama.1995.03530130055028 Jacques, 1996, Relation between folate status, a common mutation in methylenetetrahydrofolate reductase and plasma homocysteine concentrations, Circulation, 93, 7, 10.1161/01.CIR.93.1.7 Daly, 1995, Folate levels and neural tube defects: implications for prevention, JAMA, 274, 1698, 10.1001/jama.1995.03530210052030